Literature DB >> 2202157

Electrocardiographic abnormalities in patients with myotonic dystrophy.

R C Florek1, D W Triffon, D E Mann, S P Ringel, M J Reiter.   

Abstract

In examining the incidence and progression of electrocardiographic abnormalities in 45 patients with myotonic dystrophy, 26 (58%) of whom at entry had at least 1 electrocardiographic abnormality, we found conduction abnormalities in 17 (38%). In 21 patients (47%), new abnormalities developed during follow-up (mean, 4.6 years). The overall incidence of electrocardiographic abnormalities increased to 78%, and the incidence of conduction defects increased to 62%. Second-degree or complete atrioventricular block did not develop in any of the patients. Pseudoinfarction patterns were common at entry and during follow-up and were not correlated with evidence of clinical coronary artery disease. There was no correlation between the presence of electrocardiographic abnormalities and apparent disease severity.

Entities:  

Mesh:

Year:  1990        PMID: 2202157      PMCID: PMC1002461     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  24 in total

1.  MYOTONIA DYSTROPHICA WITH A-V DISSOCIATION AND STOKES-ADAMS ATTACKS: A CASE REPORT AND REVIEW OF THE LITERATURE.

Authors:  N J PETKOVICH; M DUNN; W REED
Journal:  Am Heart J       Date:  1964-09       Impact factor: 4.749

2.  MYOTONIC MUSCULAR DYSTROPHY; SYSTEMIC MANIFESTATIONS.

Authors:  J D WELSH; G R HAASE; T E BYNUM
Journal:  Arch Intern Med       Date:  1964-11

3.  DYSTROPHIA MYOTONICA. A FOLLOW-UP STUDY OF A FAMILY WITH ASSOCIATED HEART DISEASE.

Authors:  G BIOERCK; P STIGELL
Journal:  Acta Med Scand       Date:  1964-03

4.  Cardiovascular observations in dystrophia myotonica.

Authors:  L T DeWIND; R J JONES
Journal:  J Am Med Assoc       Date:  1950-09-23

5.  Lenegre's disease in youth.

Authors:  S B Dianzumba; D H Singer; S Meyers; V Barresi; N Belic; J M Smith
Journal:  Am Heart J       Date:  1977-10       Impact factor: 4.749

6.  Statistics: the problem of examining accumulating data more than once.

Authors:  K McPherson
Journal:  N Engl J Med       Date:  1974-02-28       Impact factor: 91.245

7.  Alveolar hypoventilation and hyperosmnia in myotonic dystrophy.

Authors:  G Coccagna; M Mantovani; C Parchi; F Mironi; E Lugaresi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-10       Impact factor: 10.154

8.  The heart in myotonia atrophica.

Authors:  S C Church
Journal:  Arch Intern Med       Date:  1967-02

9.  Myotonia dystrophica: ventricular arrhythmias, intraventricular conduction abnormalities, atrioventricular block and Stokes-Adams attacks successfully treated with permanent transvenous pacemaker.

Authors:  S D Clements; R A Colmers; J W Hurst
Journal:  Am J Cardiol       Date:  1976-05       Impact factor: 2.778

10.  Clinical and induced ventricular tachycardia in a patient with myotonic dystrophy.

Authors:  D S Cannom; M G Wyman; B N Goldreyer
Journal:  J Am Coll Cardiol       Date:  1984-09       Impact factor: 24.094

View more
  4 in total

1.  Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

Authors:  N R Clarke; A D Kelion; J Nixon; D Hilton-Jones; J C Forfar
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy.

Authors:  Saman Nazarian; Kathryn R Wagner; Brian S Caffo; Gordon F Tomaselli
Journal:  Pacing Clin Electrophysiol       Date:  2010-10-14       Impact factor: 1.976

3.  Analysis of Single Nucleotide Polymorphisms (SNPs) of the small-conductance calcium activated potassium channel (SK3) gene as genetic modifier of the cardiac phenotype in myotonic dystrophy type 1 patients.

Authors:  F Rinaldi; A Botta; L Vallo; G Contino; A Morgante; R Iraci; C Catalli; G Silvestri; V M Ventriglia; L Politano; G Novelli
Journal:  Acta Myol       Date:  2008-12

4.  Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration.

Authors:  Antonio Jimenez-Marin; Ibai Diez; Garazi Labayru; Andone Sistiaga; Maria C Caballero; Pol Andres-Benito; Jorge Sepulcre; Isidro Ferrer; Adolfo Lopez de Munain; Jesus M Cortes
Journal:  Neuropathol Appl Neurobiol       Date:  2021-05-17       Impact factor: 6.250

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.